Enanta Pharmaceuticals
ENTA
#8046
Rank
ยฃ0.28 B
Marketcap
ยฃ9.95
Share price
-0.44%
Change (1 day)
77.68%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ0.14 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are ยฃ0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-09-30ยฃ0.16 B-13.28%
2024-09-30ยฃ0.18 B-7.96%
2023-09-30ยฃ0.20 B314.24%
2022-09-30ยฃ48.59 M66.3%
2021-09-30ยฃ29.22 M23.55%
2020-09-30ยฃ23.65 M6.33%
2019-09-30ยฃ22.24 M41.15%
2018-09-30ยฃ15.75 M-15.42%
2017-09-30ยฃ18.63 M112.95%
2016-09-30ยฃ8.74 M34.26%
2015-09-30ยฃ6.51 M56.28%
2014-09-30ยฃ4.16 M3.76%
2013-09-30ยฃ4.01 M-21.29%
2012-09-30ยฃ5.1 M92.52%
2011-09-30ยฃ2.65 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
ยฃ88.65 B 60,322.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ58.95 B 40,080.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ105.96 B 72,117.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ5.27 B 3,495.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ61.28 B 41,670.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ49.15 B 33,402.43%๐Ÿ‡บ๐Ÿ‡ธ USA